Samphire Neuroscience has developed a neurotech wearable designed to manage menstrual symptoms by delivering low-current electrical pulses to stimulate specific brain regions, thereby alleviating pain, mood swings, and anxiety.

Company
Samphire Neuroscience
Category
Women's Health
Type
Fund I
Stage
Pre-Seed
Date
2023

About the company

Samphire Neuroscience is at the forefront of revolutionizing women's health through its groundbreaking product, FireBand. This neurotech wearable is the world's first device specifically engineered to manage menstrual symptoms by leveraging the power of neuromodulation therapy. FireBand employs low-current electrical pulses to stimulate targeted brain areas, effectively restoring balance and offering women control over various symptoms, including pain, mood swings, and anxiety. Built on a robust foundation of over 30 years of clinical research and more than 8,000 peer-reviewed papers, the device aims to empower women by nurturing their "inner flame," symbolizing their unique passion, motivation, energy, and inner strength. With a mission to eliminate compromises in women's healthcare, Samphire Neuroscience is setting new standards for effective, safe, and personalized solutions.